Addiction Treatment

FILE - In this Tuesday, June 11, 2019, file photo, marijuana equipment sits on display along a window at the Minerva medical cannabis dispensary in Santa Fe, N.M. The U.S. government is explicitly barring federal dollars for opioid addiction treatment from being used on medical marijuana. (AP Photo/Morgan Lee, File)
November 22, 2019 - 10:42 am
The U.S. government is barring federal dollars meant for opioid addiction treatment to be used on medical marijuana. The move is aimed at states that allow marijuana for medical uses, particularly those letting patients with opioid addiction use pot as a treatment, said Dr. Elinore McCance-Katz,...
Read More
FILE - In this Tuesday, June 19, 2018 file photo Cheryl Juaire walks past a photo of her son, Corey Merrill, at her home in Marlborough, Mass. Victims of opioid addiction weren’t in the room when big decisions were hammered out in OxyContin maker Purdue Pharma’s proposal to settle claims over its role in the U.S. opioid crisis. Cheryl Juaire lost her 23-year-old son to a heroin overdose after he became addicted to prescription painkillers. (AP Photo/Steven Senne, File)
October 06, 2019 - 2:50 pm
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 2:49 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
KNSS News
September 11, 2019 - 7:36 pm
The Kansas and Missouri affiliates of the American Civil Liberties Union say they have reached a settlement with the Federal Bureau of Prisons which allows an inmate to receive a drug used to treat his opioid addiction. The ACLU said in a news release Wednesday that the settlement allows the...
Read More
Judge Thad Balkman announces his decision in the Opioid Lawsuit In Norman, Okla., Monday, Aug. 26, 2019. Balkman found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis and ordered the consumer products giant to pay $572 million to help abate the problem in the coming years. (AP Photo/Sue Ogrocki, Pool)
August 27, 2019 - 6:01 pm
OKLAHOMA CITY (AP) — Oklahoma's legal fight against the opioid industry has racked up settlements and judgments of nearly $1 billion, but as the numbers keep rising, so do concerns over how that money will be spent. Experts say the $572 million judgment issued Monday against consumer products giant...
Read More
FILE - In this March 1, 2016, file photo, San Francisco police officers wait while homeless people collect their belongings in San Francisco. San Francisco supervisors consider legislation Tuesday, June 4, 2019, allowing the city to force mentally ill drug addicts into housing and treatment for up to a year. Mayor London Breed says it's inhumane to let addicts languish on the streets, but homeless advocates say the measure is extreme and a violation of civil rights. (AP Photo/Ben Margot, File)
June 04, 2019 - 8:06 pm
SAN FRANCISCO (AP) — San Francisco officials decided Tuesday to force some people with serious mental illness and drug addiction into treatment, even if it goes against the spirit of a city known for its fierce protection of civil rights. Several members of the Board of Supervisors voiced deep...
Read More
FILE - In this April 27, 2019, file photo, Democratic presidential candidate Sen. Amy Klobuchar, D-Minn., right, speaks at a Service Employees International Union forum on labor issues in Las Vegas. Klobuchar has released a plan to spend $100 billion over a decade to improve mental health care and fight substance abuse. It’s an issue the Minnesota senator has faced firsthand as the daughter of an alcoholic who struggled with addiction for years before getting sober.(AP Photo/John Locher, File)
May 03, 2019 - 7:36 am
CHICAGO (AP) — Democratic presidential candidate Amy Klobuchar has released a plan to spend $100 billion over a decade to improve mental health care and fight substance abuse, an issue the Minnesota senator has faced firsthand as the daughter of an alcoholic who struggled with addiction for years...
Read More
Oklahoma Attorney General Mike Hunter speaks about a settlement with Purdue Pharma for opioid abuse, as Oklahoma State University Center for Health Sciences President Dr. Kayse Shrum and OSU President Burns Hargis, right, listen, Tuesday, March 26, 2019. Purdue Pharma, the maker of OxyContin and the company's controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create the nation's deadly opioid crisis with their aggressive marketing of the powerful painkiller. (Mike Simons/Tulsa World via AP)
March 26, 2019 - 3:25 pm
TULSA, Okla. (AP) — The Latest on Oklahoma's lawsuit against manufacturers of opioid pain medications (all times local): 2:35 p.m. Oklahoma's attorney general says he went to great lengths to ensure that a drugmaker accused of helping to fuel a national opioid crisis doesn't declare bankruptcy to...
Read More
FILE - This July 23, 2018 file photo shows packets of buprenorphine, a drug which controls heroin and opioid cravings, in Greenfield, Mass. On Wednesday, March 20, 2019, the nation’s top medical advisers said medications which are proven to successfully treat opioid addiction remain vastly underused in the U.S., despite an epidemic of fatal overdoses tied to heroin, painkillers and related drugs. (AP Photo/Elise Amendola)
March 20, 2019 - 3:51 pm
WASHINGTON (AP) — Medicines proven to treat opioid addiction remain vastly underused in the U.S., the nation's top medical advisers said Wednesday. Only a fraction of the estimated 2 million people addicted to opioids are getting the medications, according to a report by the National Academies of...
Read More
This photo provided by Janssen Global Services shows Spravato nasal spray. Spravato, a mind-altering medication related to the club drug Special K, won U.S. approval Tuesday, March 5, 2019, for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. (Janssen Global Services via AP)
March 06, 2019 - 2:07 am
WASHINGTON (AP) — A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. The nasal spray from Johnson & Johnson...
Read More

Pages